EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Development of the Clinical Insight Questionnaire: A Novel Clinical Tool for the Assessment of Insight Into Cognitive Symptoms and Everyday Functioning in People With Neurodegeneration

Catherine Pennington iD, Harriet Ball, Peter Connelly, Elizabeth Coulthard, Gordon Duncan, Chineze Ivenso, Tobias Langheinrich iD, Vivek Pattan, Terence Quinn iD, Karen Ritchie, Craig Ritchie, Tom Russ

International Journal of Geriatric Psychiatry · 2025

DOI: 10.1002/gps.70165 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Geriatric Psychiatry, 2025. Verfasst von Catherine Pennington und 11 weiteren Autor:innen. Beteiligte Einrichtung: University of Edinburgh & NHS Lothian, Edinburgh, UK. Hauptthemen laut MEDLINE: Activities of Daily Living, Neurodegenerative Diseases, Cognitive Dysfunction. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chief Scientist Office, Scottish Government Health and Social Care Directorate.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Altered insight into cognitive symptoms and diagnosis is a common feature of neurodegeneration, and can adversely impact on quality of life and ability to access medical care. Affected individuals can lose awareness of their symptoms and therefore decline to engage with medical assessment and treatment. Assessing insight is difficult, and there is a lack of short, easily administered clinical assessment tools. The aim of this study was to develop and evaluate the feasibility of a novel insight assessment questionnaire (The Clinical Insight Questionnaire, CLIQ) which can be independently completed by adults with a range of cognitive abilities.

Methods

A discrepancy score approach was used to evaluate insight. A novel questionnaire targeting the domains of memory, personality and social behaviour, executive function, language, and activities of daily living was devised using the Delphi approach and public feedback. Participant and informant mirror versions of each item were written. The discrepancy between participant and informant scores provides an overall insight score. 12 UK based experts in cognitive disorder diagnosis and assessment were invited to review potential questionnaire items, as was a PPI group. A feasibility study was conducted where people with mild memory or thinking symptoms and an informant completed the questionnaire and the Montreal Cognitive Assessment.

Results

Following an iterative process using the expert Delphi group and public feedback, 20 final questionnaire items were selected from an initial pool of 30 items. 21 people with mild cognitive symptoms but no formally diagnosed cognitive disorder (median MoCA score 24.5) participated in feasibility testing. The mean discrepancy score was 1.14, close to the ideal score of zero. No participants found the assessment upsetting or too long, and 81% rated the questions as easy to understand.

Conclusions

The Clinical Insight Questionnaire (CLIQ) is a novel clinical tool for the assessment of insight in people with mild to moderate neurodegeneration. In feasibility testing it was quick and easy for people with mild cognitive symptoms and informants to self‐complete. Initial feasibility testing showed very promising findings for usability and acceptability, and a full validation study is now in progress.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Activities of Daily LivingNeurodegenerative DiseasesCognitive DysfunctionHumansFemaleMaleSurveys and QuestionnairesFeasibility StudiesAgedMiddle AgedDelphi TechniqueAged, 80 and overAdultNeuropsychological Tests

Stichwörter der Autor:innen

anosognosiadementiainsightmild cognitive impairmentneurodegenerationsymptom awareness

Autor:innen und Institutionen

  • University of Edinburgh & NHS Lothian, Edinburgh, UK.
  • NHS Forth Valley, Larbert, UK.
  • University of Bristol, Bristol, UK.
  • Neuroprogressive Disorders and Dementia Research Network, Dundee, UK.
  • Aneurin Bevan University Health Board, Glasgow, UK.
  • Greater Manchester Neuroscience Centre, Salford, UK.

ORCID-Profile: Catherine Pennington, Tobias Langheinrich, Terence Quinn

Förderung

  • Chief Scientist Office, Scottish Government Health and Social Care Directorate

Zitieren

APA

Pennington, C., Ball, H., Connelly, P., Coulthard, E., Duncan, G., Ivenso, C., Langheinrich, T., Pattan, V., Quinn, T., Ritchie, K., Ritchie, C., & Russ, T. (2025). Development of the Clinical Insight Questionnaire: A Novel Clinical Tool for the Assessment of Insight Into Cognitive Symptoms and Everyday Functioning in People With Neurodegeneration. International Journal of Geriatric Psychiatry. https://doi.org/10.1002/gps.70165

Vancouver

Pennington C, Ball H, Connelly P, Coulthard E, Duncan G, Ivenso C, et al. Development of the Clinical Insight Questionnaire: A Novel Clinical Tool for the Assessment of Insight Into Cognitive Symptoms and Everyday Functioning in People With Neurodegeneration. International Journal of Geriatric Psychiatry. 2025. doi:10.1002/gps.70165

BibTeX
@article{Pennington2025,
  author = {Pennington, Catherine and Ball, Harriet and Connelly, Peter and Coulthard, Elizabeth and Duncan, Gordon and Ivenso, Chineze and Langheinrich, Tobias and Pattan, Vivek and Quinn, Terence and Ritchie, Karen and Ritchie, Craig and Russ, Tom},
  title = {Development of the Clinical Insight Questionnaire: A Novel Clinical Tool for the Assessment of Insight Into Cognitive Symptoms and Everyday Functioning in People With Neurodegeneration},
  journal = {International Journal of Geriatric Psychiatry},
  year = {2025},
  doi = {10.1002/gps.70165}
}
Kostenlos starten →